Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Concord, California
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Conditions: Neuroblastoma
Location: Oklahoma City, Oklahoma
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Study of Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer
Location: Oklahoma City, Oklahoma
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Conditions: Head and Neck Cancer - Radiation Toxicity
Location: Oklahoma City, Oklahoma
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Triptorelin for Ovary Protection in Childhood Onset Lupus
Conditions: Systemic Lupus Erythematosus
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Randomized On-X Anticoagulation Trial
Conditions: Heart Valve Disease
Location: Oklahoma City, Oklahoma
- Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Conditions: Adrenocortical Carcinoma
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroect
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Oklahoma City, Oklahoma
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Oklahoma City, Oklahoma
- Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Pati
Conditions: Cervical Cancer - Endometrial Cancer
Location: Oklahoma City, Oklahoma
- Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
Conditions: Fetal Alcohol Syndrome - Attention Deficit Disorder (ADD) - Attention Deficit Disorder With Hyperactivity (ADHD)
Location: Oklahoma City, Oklahoma
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- The PACE-MI Registry Study
Conditions: Myocardial Infarction
Location: Oklahoma City, Oklahoma
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Oklahoma City, Oklahoma
- Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
Conditions: Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiatio
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Oklahoma City, Oklahoma
- Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal L
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Adult Double Cord Blood Transplant Study
Conditions: Cord Blood Stem Cell Transplantation - Hematologic Malignancies
Location: Oklahoma City, Oklahoma
- Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
Conditions: Gestational Trophoblastic Tumor
Location: Oklahoma City, Oklahoma
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Oklahoma City, Oklahoma
- Intraperitoneal Paclitaxel, Doxorubicin, and Cisplatin in Treating Patients With Endometrial Cancer
Conditions: Endometrial Cancer - Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Long-Term Follow-Up of Patients Undergoing Catheter Ablation
Conditions: Arrhythmia
Location: Oklahoma City, Oklahoma
- Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation
Conditions: Atrial Fibrillation
Location: Oklahoma City, Oklahoma
- Laparoscopic Approach to Cervical Cancer
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Home-based vs. Supervised Exercise for People With Claudication
Conditions: Intermittent Claudication
Location: Oklahoma City, Oklahoma
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- TODAY Genetics Study
Conditions: Type 2 Diabetes
Location: Oklahoma City, Oklahoma
- Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement
Conditions: Myocardial Ischemia
Location: Oklahoma, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Local Paclitaxel Delivery for SFA Disease
Conditions: Atherosclerosis - Angioplasty - Peripheral Arterial Disease
Location: Oklahoma City, Oklahoma
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Oklahoma City, Oklahoma
- Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage
Conditions: Left Atrial Appendage Occlusion
Location: Oklahoma City, Oklahoma
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Oklahoma City, Oklahoma
- Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
Conditions: Glial Cell Tumors - Malignant Gliomas
Location: Oklahoma City, Oklahoma
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
Conditions: Anxiety
Location: Oklahoma City, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Oklahoma City, Oklahoma
- Study of the Effect of Differing Platelet Transfusion Times in Neonates
Conditions: Thrombocytopenia
Location: Oklahoma City, Oklahoma
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patient
Conditions: Endometrial Cancer
Location: Oklahoma City, Oklahoma
- Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus
Location: Oklahoma City, Oklahoma
- Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Conditions: Immune Thrombocytopenic Purpura
Location: Oklahoma City, Oklahoma
- Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Conditions: Gastrointestinal Hemorrhage
Location: Oklahoma City, Oklahoma
- Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surge
Conditions: Endometrial Cancer
Location: Oklahoma City, Oklahoma
- Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
Conditions: Sepsis
Location: Oklahoma City, Oklahoma
- Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
Conditions: Sepsis
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Oklahoma City, Oklahoma
- Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Cariprazine for Mania
Conditions: Bipolar Disorder - Mania
Location: Oklahoma City, Oklahoma
- Efficacy of Statins In Prevention of CIN
Conditions: Nephropathy
Location: Oklahoma City, Oklahoma
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Elitek (Rasburicase) Immuno-Monitoring Study
Conditions: Tumor Lysis Syndrome
Location: Oklahoma City, Oklahoma
- Smoking Cessation for American Indians
Conditions: Smoking Cessation
Location: Oklahoma City, Oklahoma
- Vena Cava Filter U.S. Clinical Trial
Conditions: Pulmonary Embolism
Location: Oklahoma City, Oklahoma
- A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
Conditions: Peripheral Vascular Disease
Location: Oklahoma City, Oklahoma
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Conditions: Advanced Heart Failure
Location: Oklahoma City, Oklahoma
- Indicators of Inflammation and Coagulation in Sepsis
Conditions: Sepsis
Location: Oklahoma City, Oklahoma
- Indicators of Inflammation and Coagulation in Sepsis
Conditions: Sepsis
Location: Oklahoma City, Oklahoma
- Flail Chest - Rib Fixation Study
Conditions: Flail Chest
Location: Oklahoma City, Oklahoma
- A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Conditions: Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)
Conditions: Adult Respiratory Distress Syndrome - Acute Lung Injury
Location: Oklahoma City, Oklahoma
- Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)
Conditions: Adult Respiratory Distress Syndrome - Acute Lung Injury
Location: Oklahoma City, Oklahoma
- Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Exercise for Women With Peripheral Arterial Disease
Conditions: Peripheral Artery Disease - Claudication - Women
Location: Oklahoma City, Oklahoma
- Tumor Markers in Lung Cancer
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Conditions: Epilepsy
Location: Oklahoma City, Oklahoma
- Using Technology to Augment the Implementation and Effectiveness of PCIT
Conditions: Child Externalizing Problems
Location: Oklahoma City, Oklahoma
- Augment™ Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions
Conditions: Degenerative Joint Disease - Congenital Deformity - Arthritis - Osteoarthritis - Rheumatoid Arthritis
Location: Oklahoma City, Oklahoma
- A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System
Conditions: Pulmonary Embolism
Location: Oklahoma City, Oklahoma
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded
Conditions: Major Depressive Disorder
Location: Oklahoma City, Oklahoma
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer
Conditions: Ovarian Cancer
Location: Oklahoma City, Oklahoma
- National Marrow Donor Program Long-Term Donor Follow-Up
Conditions: Hematologic Neoplasms
Location: Oklahoma City, Oklahoma
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Conditions: Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sar
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
Location: Oklahoma City, Oklahoma
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus - Antiphospholipid Syndrome
Location: Oklahoma City, Oklahoma
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Cancer
Location: Oklahoma City, Oklahoma
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Conditions: Severe Hemophilia A
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Oklahoma City, Oklahoma
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Oklahoma City, Oklahoma
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Oklahoma City, Oklahoma
- Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Conditions: Epilepsies, Partial
Location: Edmond, Oklahoma
- Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Conditions: Epilepsies, Partial
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Oklahoma City, Oklahoma
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
Conditions: Vesico-Ureteral Reflux - Urinary Tract Infections
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Oklahoma City, Oklahoma
- Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Conditions: Invasive Fungal Infection - Aspergillosis
Location: Oklahoma City, Oklahoma
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Oklahoma City, Oklahoma
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Oklahoma City, Oklahoma
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
Conditions: Fetal Alcohol Syndrome - Attention Deficit Disorder With Hyperactivity (ADHD) - Attention Deficit Disorder (ADD)
Location: Oklahoma City, Oklahoma
- A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures
Conditions: Tibial Fractures
Location: Oklahoma City, Oklahoma
- A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Distal Femur Fractures
Conditions: Femoral Fractures
Location: Oklahoma City, Oklahoma
- Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Conditions: Bladder Cancer
Location: Oklahoma City, Oklahoma
- Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Conditions: Ototoxicity - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Oklahoma City, Oklahoma
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Oklahoma City, Oklahoma
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Oklahoma City, Oklahoma
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Oklahoma City, Oklahoma
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Cancer
Location: Oklahoma City, Oklahoma
- IGIV Study for Chronic ITP Patients Ages 3-70
Conditions: Idiopathic Thrombocytopenic Purpura
Location: Oklahoma City, Oklahoma
- A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Conditions: Influenza
Location: Oklahoma City, Oklahoma
- Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients Wit
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
Conditions: Retinoblastoma
Location: Oklahoma City, Oklahoma
- Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
Conditions: Von Willebrand Disease
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Study of Breast Cancer Prevention by Letrozole in High Risk Women
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Ablation of Inappropriate Sinus Tachycardia
Conditions: Inappropriate Sinus Tachycardia
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Oklahoma City, Oklahoma
- AV Nodal Reentrant Tachycardia Study
Conditions: Tachycardia, Atrioventricular Nodal Reentry
Location: Oklahoma City, Oklahoma
- International Hernia Mesh Registry
Conditions: Hernia
Location: Oklahoma City, Oklahoma
- Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
Conditions: Neutropenia - Infection
Location: Oklahoma City, Oklahoma
- Defibrotide for Patients With Hepatic Veno-occlusive Disease (VOD): A Treatment IND Study
Conditions: Hepatic Veno-Occlusive Disease
Location: Oklahoma City, Oklahoma
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Conditions: Venous Thrombosis
Location: Oklahoma City, Oklahoma
- CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Oklahoma City, Oklahoma
- Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury
Conditions: Scapula
Location: Oklahoma, Oklahoma
- Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study
Conditions: Atrial Septal Defect
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Oklahoma City, Oklahoma
- Prospective Observational Epidemiologic Study of Maraviroc's Safety
Conditions: Human Immunodeficiency Virus
Location: Oklahoma City, Oklahoma
- Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Conditions: Peritoneal Neoplasms
Location: Oklahoma City, Oklahoma
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Oklahoma City, Oklahoma
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Oklahoma City, Oklahoma
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
Location: Midwest City, Oklahoma
- Effects of Shrinker Use on Healing and Volume
Conditions: Transtibial Amputation
Location: Oklahoma City, Oklahoma
- Safety and Efficacy Study of Daptomycin in Pediatric Subjects (2-17 Years)With Skin and Skin Structure Infections
Conditions: Skin Diseases, Infectious
Location: Oklahoma City, Oklahoma
- 2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Ne
Conditions: Neurogenic Detrusor Overactivity
Location: Oklahoma City, Oklahoma
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
Location: Oklahoma City, Oklahoma
- Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN #0601) (The SCURT Study)
Conditions: Sickle Cell Disease
Location: Oklahoma City, Oklahoma
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors - Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity - Therapy-related Toxicity
Location: Oklahoma City, Oklahoma
- Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis - Lupus Erythematosus, Systemic
Location: Oklahoma City, Oklahoma
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
Location: Oklahoma City, Oklahoma
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Oklahoma City, Oklahoma
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Oklahoma City, Oklahoma
- Study of Sacral Fractures Using Patient Based and Objective Outcomes
Conditions: Sacrum Fracture
Location: Oklahoma City, Oklahoma
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Oklahoma City, Oklahoma
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Oklahoma City, Oklahoma
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Oklahoma City, Oklahoma
- Ultrasound Guided Arterial Line Placement in Long Axis Versus Short Axis in Pediatric Patients
Conditions: General Anesthesia
Location: Oklahoma City, Oklahoma
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Conditions: Epilepsy With Simple or Complex Partial Onset Seizures
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
Conditions: Sepsis - Acute Lung Injury - Acute Respiratory Distress Syndrome
Location: Oklahoma City, Oklahoma
- A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Cancer
Location: Oklahoma City, Oklahoma
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
Location: Oklahoma City, Oklahoma
- Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer - Precancerous Condition
Location: Oklahoma City, Oklahoma
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Oklahoma City, Oklahoma
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Oklahoma City, Oklahoma
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Oklahoma City, Oklahoma
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Oklahoma City, Oklahoma
- Collecting and Storing Tissue From Young Patients With Cancer
Conditions: Cancer
Location: Oklahoma City, Oklahoma
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Oklahoma City, Oklahoma
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Oklahoma City, Oklahoma
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Oklahoma City, Oklahoma
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Oklahoma City, Oklahoma
- Effectiveness of a Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN #0701
Conditions: Lymphoma, Non-Hodgkin
Location: Oklahoma City, Oklahoma
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia
Location: Bethany, Oklahoma
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Oklahoma City, Oklahoma
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Oklahoma City, Oklahoma
- Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Conditions: Benign Prostatic Hyperplasia (BPH)
Location: Oklahoma City, Oklahoma
- Stem Cell Related Donor Safety Study
Conditions: Related Hematopoietic Stem Cell Donors
Location: Oklahoma City, Oklahoma
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Oklahoma City, Oklahoma
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: Oklahoma City, Oklahoma
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Oklahoma City, Oklahoma
- NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation
Location: Oklahoma City, Oklahoma
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer Afte
Conditions: Cervical Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Conditions: Bladder Cancer
Location: Oklahoma City, Oklahoma
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
Conditions: Partial Epilepsy
Location: Oklahoma City, Oklahoma
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Oklahoma City, Oklahoma
- Red Cell Storage Duration Study
Conditions: Cardiac Surgery - Erythrocyte Transfusion
Location: Oklahoma City, Oklahoma
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0973 in Combination With GDC-0941 When Administered in Patients With Locally A
Conditions: Solid Cancers
Location: Oklahoma City, Oklahoma
- Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma - Lymphoproliferative Disorder
Location: Oklahoma City, Oklahoma
- Idiopathic Intracranial Hypertension Treatment Trial
Conditions: Idiopathic Intracranial Hypertension
Location: Oklahoma City, Oklahoma
- Intensive Lipid-Lowering Therapy for Patients With Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Oklahoma City, Oklahoma
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Oklahoma City, Oklahoma
- Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
Conditions: Chronic Kidney Disease - Bacterial Infection
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Conditions: Sarcoma
Location: Oklahoma City, Oklahoma
- Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Conditions: Endometrial Cancer - Endometrial Neoplasms
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Oklahoma City, Oklahoma
- Tibial Delayed Healing Pivotal Clinical Trial
Conditions: Tibial Delayed Healing
Location: Oklahoma City, Oklahoma
- Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children 10-16 With Chronic Kidney Disease (CKD).
Conditions: Chronic Kidney Disease Stage 3 and 4
Location: Oklahoma City, Oklahoma
|